King Luther Capital Management Corp Has $28.07 Million Stock Position in McKesson Corporation $MCK

King Luther Capital Management Corp boosted its holdings in shares of McKesson Corporation (NYSE:MCK) by 6.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,340 shares of the company’s stock after acquiring an additional 2,359 shares during the period. King Luther Capital Management Corp’s holdings in McKesson were worth $28,074,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of MCK. Brighton Jones LLC increased its stake in McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of McKesson in the first quarter valued at about $233,000. Sivia Capital Partners LLC boosted its position in McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares during the last quarter. Chicago Partners Investment Group LLC raised its stake in shares of McKesson by 16.3% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 1,069 shares of the company’s stock worth $763,000 after purchasing an additional 150 shares in the last quarter. Finally, Bogart Wealth LLC boosted its holdings in shares of McKesson by 122.6% in the 2nd quarter. Bogart Wealth LLC now owns 118 shares of the company’s stock valued at $86,000 after buying an additional 65 shares during the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of a number of recent analyst reports. Mizuho boosted their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. JPMorgan Chase & Co. upped their price objective on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Finally, Barclays upped their price target on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $943.50.

McKesson Stock Up 0.0%

Shares of NYSE:MCK opened at $946.52 on Thursday. The firm has a market cap of $115.94 billion, a P/E ratio of 27.22, a P/E/G ratio of 1.52 and a beta of 0.40. The business has a fifty day simple moving average of $848.54 and a 200 day simple moving average of $793.10. McKesson Corporation has a 12-month low of $594.34 and a 12-month high of $971.93.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Buying and Selling

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 794 shares of company stock worth $718,056 in the last quarter. Insiders own 0.08% of the company’s stock.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.